IDEXX Laboratories (IDXX) Financials: Revenue & Earnings
$44.64B
Market Cap
40.04
P/E
38.36
Forward P/E
53
Score
IDXX price $566.67 +5.42 +0.97%
Stocklytics score rationale: value 29, quality 73, growth 58.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 1775423000 | 1969058000 | 2213242000 | 2406908000 | 2706655000 | 3215360000 | 3367324000 | 3660953000 | 3897504000 | 4303702000 |
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality…
IDXX fair value $442.01. Price $566.67. Price is 28% above fair value.
Above fair value, but less expensive than usual. A smaller premium than on 93% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 1.25B. Growth 15.19%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.5). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 78.78M. Net debt 897.14M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-02 | — | 3.72 | — | 1.19B |
| 2026-08-04 | 4.27 | 3.94 | 1.22B | 1.20B |
| 2026-05-05 | 3.47 | 3.41 | 1.14B | 1.12B |
| 2026-02-02 | 3.08 | 2.93 | 1.09B | 1.07B |
| 2025-11-03 | 3.40 | 3.14 | 1.11B | 1.07B |
| 2025-08-04 | 3.63 | 3.28 | 1.11B | 1.06B |
| 2025-05-01 | 2.96 | 2.85 | 998.43M | 997.10M |
| 2025-02-03 | 2.62 | 2.39 | 954.29M | 935.15M |
| 2024-10-31 | 2.80 | 2.68 | 975.54M | 980.32M |
| 2024-08-06 | 3.02 | 2.88 | 1.00B | 1.01B |
| 2024-05-01 | 2.81 | 2.67 | 964.10M | 964.41M |
| 2024-02-05 | 2.32 | 2.12 | 901.60M | 891.25M |
| 2023-11-01 | 2.53 | 2.37 | 915.53M | 926.76M |
| 2023-08-01 | 2.67 | 2.47 | 943.63M | 934.42M |
| 2023-05-02 | 2.55 | 2.42 | 900.20M | 892.47M |
| 2023-02-06 | 2.05 | 1.94 | 828.57M | 820.91M |
| 2022-11-01 | 2.15 | 2.04 | 841.66M | 830.00M |
| 2022-08-02 | 1.56 | 1.56 | 860.55M | 863.14M |
| 2022-05-04 | 2.27 | 2.26 | 836.55M | 837.10M |
| 2022-02-02 | 1.89 | 1.71 | 801.09M | 781.83M |
| 2021-11-02 | 2.03 | 1.91 | 810.42M | 797.10M |
| 2021-07-30 | 2.34 | 2.02 | 826.14M | 786.32M |
| 2021-05-04 | 2.35 | 1.72 | 777.71M | 740.74M |
| 2021-02-02 | 2.01 | 1.40 | 720.94M | 671.24M |
| 2020-10-29 | 1.69 | 1.43 | 721.79M | 610.74M |
| 2020-07-31 | 1.72 | 1.17 | 637.59M | 433.71M |
| 2020-04-30 | 1.29 | 1.20 | 626.34M | 582.64M |
| 2020-01-31 | 1.04 | 0.90 | 605.45M | 529.77M |
| 2019-10-31 | 1.24 | 1.14 | 605.30M | 556.49M |
| 2019-08-01 | 1.43 | 1.37 | 620.10M | 594.08M |
| 2019-05-01 | 1.17 | 1.05 | 576.06M | 516.97M |
| 2019-02-01 | 0.98 | 0.90 | 549.39M | 504.54M |
| 2018-11-01 | 1.05 | 0.97 | 545.45M | 503.85M |
| 2018-08-01 | 1.23 | 1.17 | 580.75M | 552.47M |
| 2018-05-04 | 1.01 | 0.92 | 537.66M | 495.11M |
| 2018-02-01 | 0.77 | 0.73 | 506.12M | 479.81M |
| 2017-10-31 | 0.79 | 0.74 | 491.98M | 460.86M |
| 2017-08-01 | 0.95 | 0.85 | 508.94M | 455.33M |
| 2017-04-28 | 0.77 | 0.61 | 462.02M | 366.00M |
| 2017-02-02 | 0.58 | 0.51 | 443.00M | 389.53M |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-04 | Kingsley Lawrence D | Buy | 2.20K | $114.17 | 251.52K |
| 2026-09-04 | Kingsley Lawrence D | Sell | 2.20K | $532.08 | 1.17M |
| 2026-09-04 | Kingsley Lawrence D | Sell | 2.20K | $114.17 | 251.52K |
| 2026-08-20 | Emerson Andrew | Buy | 265 | $178.26 | 47.24K |
| 2026-08-20 | Emerson Andrew | Sell | 86 | — | — |
| 2026-08-20 | Emerson Andrew | Sell | 265 | $178.26 | 47.24K |
| 2026-07-30 | HOOLEY JOSEPH L | Buy | 49 | $558.80 | 27.38K |
| 2026-06-01 | FENNELL GEORGE | Buy | 639 | — | — |
| 2026-06-01 | FENNELL GEORGE | Sell | 284 | $566.79 | 160.97K |
| 2026-06-01 | FENNELL GEORGE | Sell | 639 | — | — |
| 2026-05-12 | Vandebroek Sophie V. | Buy | 525 | $533.92 | 280.31K |
| 2026-05-12 | Vandebroek Sophie V. | Buy | 234 | — | — |
| 2026-05-12 | SAMAD SAM | Buy | 234 | — | — |
| 2026-05-12 | SAMAD SAM | Buy | 525 | $533.92 | 280.31K |
| 2026-05-12 | Peacock Karen | Buy | 525 | $533.92 | 280.31K |
| 2026-05-12 | Peacock Karen | Buy | 234 | — | — |
| 2026-05-12 | Kingsley Lawrence D | Buy | 525 | $533.92 | 280.31K |
| 2026-05-12 | Kingsley Lawrence D | Buy | 234 | — | — |
| 2026-05-12 | Kingsley Lawrence D | Buy | 168 | $533.92 | 89.70K |
| 2026-05-12 | Kingsley Lawrence D | Buy | 75 | — | — |
| 2026-05-12 | JUNIUS DANIEL M | Buy | 525 | $533.92 | 280.31K |
| 2026-05-12 | JUNIUS DANIEL M | Buy | 234 | — | — |
| 2026-05-12 | HOOLEY JOSEPH L | Buy | 525 | $533.92 | 280.31K |
| 2026-05-12 | HOOLEY JOSEPH L | Buy | 234 | — | — |
| 2026-05-12 | ESSIG STUART | Buy | 525 | $533.92 | 280.31K |
| 2026-05-12 | ESSIG STUART | Buy | 234 | — | — |
| 2026-05-12 | Claflin Bruce L. | Buy | 234 | — | — |
| 2026-05-12 | Claflin Bruce L. | Buy | 525 | $533.92 | 280.31K |
| 2026-05-12 | Britt Irene Chang | Buy | 234 | — | — |
| 2026-05-12 | Britt Irene Chang | Buy | 525 | $533.92 | 280.31K |
| 2026-05-07 | Vandebroek Sophie V. | Buy | 257 | — | — |
| 2026-05-07 | Vandebroek Sophie V. | Sell | 257 | — | — |
| 2026-05-07 | SZOSTAK M ANNE | Buy | 257 | — | — |
| 2026-05-07 | SZOSTAK M ANNE | Sell | 257 | — | — |
| 2026-05-07 | Peacock Karen | Buy | 101 | — | — |
| 2026-05-07 | Peacock Karen | Sell | 101 | — | — |
| 2026-05-07 | Kingsley Lawrence D | Buy | 82 | — | — |
| 2026-05-07 | Kingsley Lawrence D | Buy | 257 | — | — |
| 2026-05-07 | Kingsley Lawrence D | Sell | 82 | — | — |
| 2026-05-07 | JUNIUS DANIEL M | Buy | 257 | — | — |
| 2026-05-07 | JUNIUS DANIEL M | Sell | 257 | — | — |
| 2026-05-07 | HOOLEY JOSEPH L | Buy | 158 | — | — |
| 2026-05-07 | HOOLEY JOSEPH L | Sell | 158 | — | — |
| 2026-04-30 | HOOLEY JOSEPH L | Buy | 43 | $560.80 | 24.11K |
| 2026-03-03 | Underberg Sharon E. | Buy | 197 | $505.53 | 99.59K |
| 2026-03-03 | Underberg Sharon E. | Sell | 197 | $505.53 | 99.59K |
| 2026-03-03 | Hunt Nimrata | Sell | 1.76K | $634.57 | 1.12M |
| 2026-02-27 | MAZELSKY JONATHAN JAY | Buy | 197 | $505.53 | 99.59K |
| 2026-02-27 | MAZELSKY JONATHAN JAY | Sell | 197 | $505.53 | 99.59K |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Buy | 23.33K | $141.60 | 3.30M |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Sell | 1.28K | $650.67 | 833.51K |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Sell | 1.09K | $651.49 | 713.38K |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Sell | 1.67K | $652.49 | 1.09M |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Sell | 1.17K | $653.68 | 765.45K |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Sell | 1.11K | $654.63 | 727.29K |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Sell | 1.49K | $655.85 | 975.90K |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Sell | 1.34K | $656.85 | 882.14K |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Sell | 2.86K | $657.84 | 1.88M |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Sell | 3.66K | $658.92 | 2.41M |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Sell | 2.86K | $659.75 | 1.89M |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Sell | 1.20K | $661.10 | 793.32K |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Sell | 1.00K | $662.16 | 662.16K |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Sell | 2.59K | $663.04 | 1.72M |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Sell | 23.33K | $141.60 | 3.30M |
| 2026-02-26 | Hunt Nimrata | Sell | 2.69K | $661.54 | 1.78M |
| 2026-02-19 | Erickson Michael G | Buy | 197 | $505.53 | 99.59K |
| 2026-02-19 | Erickson Michael G | Buy | 183 | $544.08 | 99.57K |
| 2026-02-19 | Erickson Michael G | Buy | 483 | $206.94 | 99.95K |
| 2026-02-19 | Erickson Michael G | Buy | 817 | $178.26 | 145.64K |
| 2026-02-19 | Erickson Michael G | Buy | 719 | $141.60 | 101.81K |
| 2026-02-19 | Erickson Michael G | Sell | 197 | $505.53 | 99.59K |
| 2026-02-19 | Erickson Michael G | Sell | 183 | $544.08 | 99.57K |
| 2026-02-19 | Erickson Michael G | Sell | 483 | $206.94 | 99.95K |
| 2026-02-19 | Erickson Michael G | Sell | 817 | $178.26 | 145.64K |
| 2026-02-19 | Erickson Michael G | Sell | 719 | $141.60 | 101.81K |
| 2026-02-17 | Erickson Michael G | Buy | 4.18K | $178.26 | 745.13K |
| 2026-02-17 | Erickson Michael G | Sell | 456 | $623.76 | 284.43K |
| 2026-02-17 | Erickson Michael G | Sell | 204 | $625.24 | 127.55K |
| 2026-02-17 | Erickson Michael G | Sell | 1.29K | $626.26 | 806.62K |
| 2026-02-17 | Erickson Michael G | Buy | 1.19K | $141.60 | 168.65K |
| 2026-02-17 | Erickson Michael G | Sell | 2.69K | $628.22 | 1.69M |
| 2026-02-17 | Erickson Michael G | Sell | 689 | $629.09 | 433.44K |
| 2026-02-17 | Erickson Michael G | Sell | 40 | $629.86 | 25.19K |
| 2026-02-17 | Erickson Michael G | Sell | 4.18K | $178.26 | 745.13K |
| 2026-02-17 | Erickson Michael G | Sell | 1.19K | $141.60 | 168.65K |
| 2026-02-17 | Vandebroek Sophie V. | Buy | 945 | $333.90 | 315.54K |
| 2026-02-17 | Vandebroek Sophie V. | Sell | 945 | $628.65 | 594.07K |
| 2026-02-17 | Vandebroek Sophie V. | Sell | 519 | $628.56 | 326.22K |
| 2026-02-17 | Vandebroek Sophie V. | Sell | 945 | $333.90 | 315.54K |
| 2026-02-14 | Underberg Sharon E. | Buy | 265 | — | — |
| 2026-02-14 | Underberg Sharon E. | Sell | 251 | $629.35 | 157.97K |
| 2026-02-14 | Underberg Sharon E. | Buy | 218 | — | — |
| 2026-02-14 | Underberg Sharon E. | Buy | 176 | — | — |
| 2026-02-14 | Underberg Sharon E. | Buy | 173 | — | — |
| 2026-02-14 | Underberg Sharon E. | Sell | 265 | — | — |
| 2026-02-14 | Underberg Sharon E. | Sell | 218 | — | — |
| 2026-02-14 | Underberg Sharon E. | Sell | 176 | — | — |
| 2026-02-14 | Underberg Sharon E. | Sell | 173 | — | — |
| 2026-02-14 | Smith Martin Alexander | Buy | 367 | — | — |
| 2026-02-14 | Smith Martin Alexander | Sell | 302 | $629.35 | 190.06K |
Latest filed quarter: Q2 2026.
Institutions holding: 1.33K, holders -14 vs prior quarter. Ownership 93.73%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 8.17M | -195.38K | -2.34% | 4.30B |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.15M | -30.29K | -0.58% | 2.71B |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.90M | -14.34K | -0.37% | 2.05B |
| STATE STREET CORP | 3.75M | 74.47K | +2.03% | 1.97B |
| INVESCO LTD. | 3.61M | 1.94M | +116.11% | 1.90B |
| GEODE CAPITAL MANAGEMENT, LLC | 2.56M | -98.11K | -3.69% | 1.35B |
| BAMCO INC /NY/ | 1.98M | 343.41K | +21.02% | 1.04B |
| MORGAN STANLEY | 1.36M | 40.15K | +3.05% | 713.91M |
| BANK OF NEW YORK MELLON CORP | 1.19M | -311.19K | -20.68% | 628.22M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.07M | 228.24K | +27.21% | 561.75M |
| FUNDSMITH LLP | 1.02M | -445.90K | -30.42% | 536.91M |
| BLAIR WILLIAM & CO/IL | 918.56K | -27.78K | -2.94% | 483.56M |
| NORTHERN TRUST CORP | 918.14K | 6.24K | +0.68% | 483.34M |
| UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC | 911.49K | 39.70K | +4.55% | 479.84M |
| FMR LLC | 822.64K | 539.67K | +190.71% | 433.07M |
| AMERICAN CENTURY COMPANIES INC | 808.36K | 208.43K | +34.74% | 425.55M |
| CAPITAL RESEARCH GLOBAL INVESTORS | 789.11K | 7.77K | +0.99% | 415.47M |
| JPMORGAN CHASE & CO | 755.79K | -24.09K | -3.09% | 405.05M |
| PRINCIPAL FINANCIAL GROUP INC | 743.25K | -137.94K | -15.65% | 391.30M |
| GOLDMAN SACHS GROUP INC | 738.71K | 21.79K | +3.04% | 388.89M |
| WELLINGTON MANAGEMENT GROUP LLP | 726.70K | -8.78K | -1.19% | 382.56M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 650.43K | 650.43K | New | 342.41M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 650.43K | 40.21K | +6.59% | 342.41M |
| LEGAL & GENERAL GROUP PLC | 617.20K | -33.61K | -5.16% | 324.92M |
| DIMENSIONAL FUND ADVISORS LP | 608.90K | 35.57K | +6.20% | 320.59M |
IDEXX Laboratories, Inc. (IDXX) trades at $566.67, with a market cap of $44.64B and a trailing P/E of 40.04. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 1775423000 | 1969058000 | 2213242000 | 2406908000 | 2706655000 | 3215360000 | 3367324000 | 3660953000 | 3897504000 | 4303702000 |
Insights · Dividends · Forecast · Financials · Learn
$44.64B
Market Cap
40.04
P/E
38.36
Forward P/E
53
Score